Optimization of Treatment Intervals of Tocilizumab and Golimumab By Measuring Serum Trough Levels in Rheumatoid Arthritis Patients

被引：0
|
作者：
Matsuura, Yoshinobu [1 ]
Narazaki, Masashi [2 ]
Nishide, Masayuki [2 ]
Kato, Yasuhiro [2 ]
Yorifuji, Hideki [2 ]
Hirano, Toru [3 ]
Shima, Yoshihito [3 ]
Tanaka, Toshio [2 ]
Ogata, Atsushi [2 ,4 ]
Kumanogoh, Atsushi [3 ]
机构：
[1] Osaka Univ, Grad Sch Med, Internal Med Allergy & Rheumat Dis, Suita, Osaka, Japan
[2] Osaka Univ, Grad Sch Med, Suita, Osaka, Japan
[3] Osaka Univ, Grad Sch Med, Resp Med Allergy & Rheumat Dis, Suita, Osaka, Japan
[4] NTT West Osaka Hosp, Osaka, Japan
来源：
ARTHRITIS & RHEUMATOLOGY | 2015年 / 67卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
581
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Tocilizumab Serum Trough Levels and Disease Activity in Rheumatoid Arthritis
    Ruiz-Esquide, Virginia
    Zufferey, Pascal
    Inciarte-Mundo, Jose
    Yaguee, Jordi
    Victoria Hernandez, M.
    Ramirez, Julio
    Berner, Jeanne
    Pascal, Mariona
    Cuervo, Andrea
    Canete, Juan D.
    Sanmarti, Raimon
    [J]. ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [2] TOCILIZUMAB SERUM TROUGH LEVELS CORRELATE WITH CLINICAL ACTIVITY IN RHEUMATOID ARTHRITIS
    Tornero Marin, C.
    Plasencia, C.
    Pascual Salcedo, D.
    Jurado, T.
    Paredes, M. B.
    Monjo, I.
    Moral, E.
    Pieren, A.
    Bonilla Hernan, G.
    Peiteado, D.
    Bogas, P.
    Nuno, L.
    Villalba Yllan, A.
    Martin Mola, E.
    Balsa Criado, A.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 722 - 723
  • [3] Tocilizumab Serum Trough Levels and Its Relationship with Disease Activity and Drug Dosage in Rheumatoid Arthritis Patients
    Ruiz-Esquide, Virginia
    Gonzalez-Navarro, Azucena
    Yaguee, Jordi
    Inciarte-Mundo, Jose
    Victoria Hernandez, M.
    Ramirez, Julio
    Cabrera-Villalba, Sonia
    Canete, Juan D.
    Sanmarti, Raimon
    [J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1096 - S1096
  • [4] Effectiveness of golimumab for rheumatoid arthritis in patients with an inadequate response to tocilizumab
    Matsuno, Hiroaki
    Katayama, Kou
    [J]. MODERN RHEUMATOLOGY, 2017, 27 (02) : 246 - 251
  • [5] Variability of rituximab and tocilizumab trough concentrations in patients with rheumatoid arthritis
    Truffot, Aurelie
    Gautier-Veyret, Elodie
    Baillet, Athan
    Jourdil, Jean-Francois
    Stanke-Labesque, Francoise
    Gottenberg, Jacques-Eric
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2021, 35 (06) : 1090 - 1099
  • [6] RELATIONSHIP BETWEEN CLINICAL REMISSION AND SERUM LEVELS OF TOCILIZUMAB IN THE TREATMENT OF RHEUMATOID ARTHRITIS
    Ruiz-Esquide, V.
    Zufferey, P.
    Yaguee, J.
    Berner, J.
    Inciarte-Mundo, J.
    Gonzalez-Navarro, A.
    Hernandez, V.
    Ramirez, J.
    Cuervo, A.
    Canete, J.
    Sanmarti, R.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 77 - 77
  • [7] Predictive value of infliximab serum trough levels for response in patients with rheumatoid arthritis
    Van den Bemt, Bart
    Den Broeder, Alfons A.
    Wolbink, Gert-jan
    Hekster, Yechiel A.
    Van Riel, Piet L. C. M.
    Benraad, Bart
    Van den Hoogen, Frank H. J.
    [J]. PHARMACY WORLD & SCIENCE, 2010, 32 (02): : 283 - 283
  • [8] ISTHERE AN EFFECT OF TOCILIZUMAB IN SERUM AUTOANTIBODIES LEVELS IN RHEUMATOID ARTHRITIS?
    Guerra, Miguel
    Ganhao, Sara
    Martins-Rocha, Teresa
    Ferreira, Raquel
    Fernandes, Bruno Miguel
    Garcia, Salome
    Agueda, Ana Filipa
    Pimenta, Sofia
    Bernardo, Alexandra
    Bernardes, Miguel
    Costa, Lucia
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1650 - 1650
  • [9] Golimumab trough levels, antidrug antibodies and clinical response in patients with rheumatoid arthritis treated in daily clinical practice
    Kneepkens, Eva L.
    Plasencia, Chamaida
    Krieckaert, Charlotte L. M.
    Pascual-Salcedo, Dora
    van der Kleij, Desiree
    Nurmohamed, Michael T.
    Teresa Lopez-Casla, M.
    Wieringa, Roeland
    Rispens, Theo
    Wolbink, Gertjan
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (12) : 2217 - U225
  • [10] Immunogenicity, drug trough levels and therapeutic response in patients with rheumatoid arthritis or ankylosing spondylitis after 24-week golimumab treatment
    Chen, Der-Yuan
    Chen, Yi-Ming
    Hung, Wei-Ting
    Chen, Hsin-Hua
    Hsieh, Chia-Wei
    Chen, Yi-Hsing
    Huang, Wen-Nan
    Hsieh, Tsu-Yi
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (12) : 2261 - 2264
12345